Login

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Assets
Fair value
Non Controlled or Non Affiliated Investments
Affiliated Investments
Investment, Unaffiliated Issuer
Investment, Affiliated Issuer, Noncontrolled
Investment, Affiliated Issuer, Controlled
Total fair value
Cash and cash equivalents
Receivable for investments sold
Dividends and interest receivable
Receivable from Adviser
Prepaid expenses
Deferred tax asset
Other receivables
Total assets
Liabilities
Payable for fund shares repurchased
Payable to Adviser
Accrued expenses and other liabilities
Distributions payable
Deferred tax liability
Total liabilities
Net assets
Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)
Common stock, $0.001 par value (200,000,000 shares authorized, 8,295,947 and 8,359,344 shares issued and outstanding, respectively)
Paid-in capital in excess of par
Distributable earnings (accumulated loss)
Total net assets
Net asset value per share of common stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support